Indian Immunologicals Limited

Celebrating a Lifetime of Excellence. A Legacy That Inspires. Indian Immunologicals Limited (IIL) takes immense pride in congratulating our Managing Director, Dr. K. Anand Kumar, on being conferred with the prestigious FABA Lifetime Achievement Award by the Federation of Asian Biotech Associations (@bio_faba). This distinguished recognition honours his outstanding contributions to biotechnology, vaccine research, development, manufacturing and his unwavering commitment to advancing human and animal healthcare. Previous recipients of this prestigious award include Serum Institute of India CMD Cyrus Poonawalla; Patrick Vallance, former President of R&D at GlaxoSmithKline; Dr. Balram Bhargava, former Director General of ICMR; and Dr. Soumya Swaminathan, former Chief Scientist of the World Health Organization. Under his visionary leadership, IIL has continued to strengthen its position as one of India's leading vaccine manufacturers, contributing significantly to the nation's vaccine self-reliance and the availability of quality, affordable vaccines for both human and animal health. His distinguished journey is a testament to visionary leadership, an unwavering pursuit of scientific excellence and an enduring commitment to the larger mission of safeguarding lives through preventive healthcare. While this award recognises his exceptional journey, it also celebrates the collective efforts of the scientists, researchers, healthcare professionals and the entire IIL family who share this mission. Congratulations, Dr. Anand Kumar! This recognition is a moment of immense pride for the entire IIL family and an inspiration to continue pushing boundaries in science, innovation and healthcare. @NDDB_Coop #FABA #LifetimeAchievementAward #LeadershipExcellence #Biotechnology #VaccineInnovation #VaccineResearch #HealthcareInnovation #MakeInIndia #VaccineSelfReliance #HumanHealth #AnimalHealth #PreventiveHealthcare

Today our MD Dr.K.Anand Kumar as a Professor of Practice interacted with the students and faculty at the Indian Veterinary Research Institute (ICAR), Bareilly, UP. Dr.Kumar shared his life experiences and assured that success is guaranteed when one follows discipline and gets the basics right. He requested students to acquire as many skills as possible to enable translation of knowledge into something tangible. He highlighted the importance of Networking and embracing Volunteerism. He requested students to never deviate from values even when circumstances are adverse. He mentioned the importance of Gratitude and how Empathy & Sympathy play a vital role without which leaders will never be respected. He emphasised that all students other than their technical learning should also have a good grasp on Marketing and Finance. He also touched upon topics related to Sustainability, AI and automation. He requested students to take up awareness campaigns to impart knowledge to the society on responsible consumerism and reduce wastage. Community work, he said gives the maximum satisfaction. He ended saying “Success is not only about how much you have progressed, it’s about how many other lives you have touched upon." @ivri_1889 #IIL #NDDB #ICAR #OneHealth #Leadership #SkillDevelopment #Sustainability #ArtificialIntelligence

It was an exciting moment for Indian Immunologicals Limited (IIL) at CPHI Milan 2026. We were delighted to welcome many visitors to our stand, engaging in meaningful discussions with existing partners and exploring new opportunities for collaboration across global markets. A particular highlight was the visit of Mr. Lavanya Kumar, Counsellor at the Consulate General of India, Milan, who spent time with Dr.K.Anand Kumar, MD, learning about IIL's journey, our operations, and our contribution to improving human and animal health through accessible healthcare solutions. As we celebrate 40 Years of Saving Lives, this strong start to CPHI Milan energises us further. We look forward to building new relationships, reaching new markets, and expanding our impact through vaccines, animal health solutions, and public health initiatives. Together, we shall continue to fight disease, improve lives, and make the world a healthier and safer place. Visit us at Stand 20F42 CPHI Milan 2026 @CPHI_Events #CPHIMilan2026 #IndianImmunologicals #IIL #Vaccines #GlobalHealth #OneHealth #Partnerships

𝗜𝗻𝗱𝗶𝗮𝗻 𝗜𝗺𝗺𝘂𝗻𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹𝘀 𝗟𝗶𝗺𝗶𝘁𝗲𝗱 (𝗜𝗜𝗟) is delighted to celebrate a proud moment as Dr Meenesh Shah, Chairman, NDDB & IIL, receives the prestigious 𝗔𝗚𝗥𝗜𝟭𝟬𝟬 𝗞𝗿𝗶𝘀𝗵𝗶 𝗝𝗮𝗴𝗿𝗮𝗻 𝗔𝗴𝗿𝗶𝗰𝘂𝗹𝘁𝘂𝗿𝗲 𝗟𝗲𝗮𝗱𝗲𝗿𝘀𝗵𝗶𝗽 𝗔𝘄𝗮𝗿𝗱 𝟮𝟬𝟮𝟲. This distinguished honor celebrates Dr Shah’s exemplary leadership and his continued efforts towards strengthening India’s dairy, agriculture and allied sectors empowering farmers and contributing to the growth and sustainability of the rural economy. At IIL, we take immense pride in being part of the NDDB family and in witnessing this well-deserved recognition of a leader whose vision and commitment continue to create a stronger and more sustainable agricultural ecosystem. Congratulations to Dr Meenesh Shah on this distinguished achievement. @NDDB_Coop #IIL #NDDB #OneHealth

The wait is almost over. Next week, 𝗜𝗻𝗱𝗶𝗮𝗻 𝗜𝗺𝗺𝘂𝗻𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹𝘀 𝗟𝗶𝗺𝗶𝘁𝗲𝗱 (𝗜𝗜𝗟) will be at 𝗖𝗣𝗛𝗜 𝗠𝗶𝗹𝗮𝗻 𝟮𝟬𝟮𝟲, looking forward to engaging with partners and healthcare leaders from around the world. As we celebrate "𝟰𝟬 𝘆𝗲𝗮𝗿𝘀 𝗼𝗳 𝗧𝗼𝘂𝗰𝗵𝗶𝗻𝗴 𝗟𝗶𝘃𝗲𝘀 𝗮𝗻𝗱 𝗠𝗮𝗸𝗶𝗻𝗴 𝗮 𝗗𝗶𝗳𝗳𝗲𝗿𝗲𝗻𝗰𝗲", we are excited to showcase not only our established human and animal health portfolio, but also some of our newest additions: 🔹 𝗘𝗠𝗔𝗥𝗦𝘂𝗿𝗲 - Measles & Rubella (MR) Vaccine 🔹 𝗧𝗱𝗦𝘂𝗿𝗲 - Tetanus & Diphtheria (Td) Vaccine 🔹 𝗘𝗹𝗼𝘃𝗮 𝗔 - Hepatitis A Vaccine In addition, we are expanding our reach beyond vaccines with a growing portfolio of 𝗘𝘁𝗵𝗻𝗼𝘃𝗲𝘁𝗲𝗿𝗶𝗻𝗮𝗿𝘆 𝗮𝗻𝗱 𝗔𝗾𝘂𝗮𝗰𝘂𝗹𝘁𝘂𝗿𝗲 𝗛𝗲𝗮𝗹𝘁𝗵 𝗦𝘂𝗽𝗽𝗹𝗲𝗺𝗲𝗻𝘁𝘀, supporting animal health, productivity, and sustainable farming practices. At IIL, we believe that innovation is meaningful only when it improves lives. Whether through preventive healthcare, animal health solutions, or wellness products, our mission remains unchanged: improving access, enhancing health outcomes, and creating lasting impact. 𝗩𝗶𝘀𝗶𝘁 𝘂𝘀 𝗮𝘁 𝗦𝘁𝗮𝗻𝗱 𝟮𝟬𝗙𝟰𝟮 𝟲-𝟴 𝗢𝗰𝘁𝗼𝗯𝗲𝗿 𝟮𝟬𝟮𝟲 | 𝗠𝗶𝗹𝗮𝗻, 𝗜𝘁𝗮𝗹𝘆 We invite distributors, public health organizations, animal health companies, aquaculture partners, and collaborators to explore opportunities to work together. 𝗧𝗵𝗲 𝗺𝗼𝘀𝘁 𝗶𝗺𝗽𝗮𝗰𝘁𝗳𝘂𝗹 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝘀𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀 𝗮𝗿𝗲 𝗯𝘂𝗶𝗹𝘁 𝘁𝗵𝗿𝗼𝘂𝗴𝗵 𝗰𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻. 𝗜𝗳 𝘆𝗼𝘂'𝗿𝗲 𝗮𝘁𝘁𝗲𝗻𝗱𝗶𝗻𝗴 𝗖𝗣𝗛𝗜 𝗠𝗶𝗹𝗮𝗻, 𝗹𝗲𝘁'𝘀 𝗰𝗼𝗻𝗻𝗲𝗰𝘁 𝗮𝗻𝗱 𝗲𝘅𝗽𝗹𝗼𝗿𝗲 𝗵𝗼𝘄 𝘁𝗼𝗴𝗲𝘁𝗵𝗲𝗿 𝘄𝗲 𝗰𝗮𝗻 𝗰𝗿𝗲𝗮𝘁𝗲 𝗵𝗲𝗮𝗹𝘁𝗵𝗶𝗲𝗿 𝗰𝗼𝗺𝗺𝘂𝗻𝗶𝘁𝗶𝗲𝘀 𝗮𝗻𝗱 𝗮 𝘀𝗮𝗳𝗲𝗿 𝘄𝗼𝗿𝗹𝗱. #CPHIMilan2026 #IndianImmunologicals #IIL #Vaccines #EMARSure #TdSure #ElovaA #HepatitisA #AnimalHealth #Aquaculture #Ethnoveterinary #GlobalHealth #Partnerships #Innovation #HealthcareForAll #TouchingLivesMakingADifference #40YearsOfSavingLives

You can’t watch every moment but can prepare for the unexpected. A tiny scratch may go unnoticed. A child may not always tell you. But when it comes to Rabies, every potential exposure matters. This World Rabies Day, 28th September, learn about Rabies Pre-Exposure Prophylaxis (PrEP) and talk to your doctor about it. Because protection begins before the unexpected happens. Educate. Vaccinate. Eliminate. Be Fearless Against Rabies. #WorldRabiesDay #Rabies #RabiesPrEP #PreExposureProphylaxis #RabiesPrevention #ChildHealth #ParentAwareness #BeFearlessAgainstRabies

We are proud to share our participation in the 𝗗𝗖𝗩𝗠𝗡 𝗔𝗚𝗠 𝟮𝟬𝟮𝟲, one of the most important global forums bringing together vaccine manufacturers, public health organizations, policymakers, and industry leaders committed to improving equitable access to vaccines worldwide. A key highlight was the 𝗖𝗘𝗢 𝗙𝗼𝗿𝘂𝗺, where our Managing Director, Dr. K. Anand Kumar, joined an esteemed panel of global vaccine leaders including 𝗗𝗿. 𝗫𝗶𝘂𝗹𝗶𝗻𝗴 𝗟𝗶 (𝗦𝗶𝗻𝗼𝗽𝗵𝗮𝗿𝗺-𝗖𝗡𝗕𝗚, 𝗖𝗵𝗶𝗻𝗮), 𝗠𝗿. 𝗫𝗶𝗮𝗼𝗾𝗶 𝗡𝗶𝗲 (𝗕𝗶𝗼𝗸𝗮𝗻𝗴𝘁𝗮𝗶), 𝗗𝗿. 𝗦𝗵𝗼𝘂𝗯𝗮𝗶 𝗖𝗵𝗮𝗼 (𝗖𝗮𝗻𝗦𝗶𝗻𝗼 𝗕𝗶𝗼𝗹𝗼𝗴𝗶𝗰𝘀), 𝗗𝗿. 𝗔𝘀𝘀𝗶𝗲𝘁𝗼𝘂 𝗗𝗶𝗼𝘂𝗳 (𝗩𝗮𝘅𝗦𝗲𝗻, 𝗔𝗳𝗿𝗶𝗰𝗮), 𝗗𝗿. 𝗥𝗼𝘀𝗮𝗻𝗲 𝗖𝘂𝗯𝗲𝗿 (𝗕𝗶𝗼-𝗠𝗮𝗻𝗴𝘂𝗶𝗻𝗵𝗼𝘀/𝗙𝗶𝗼𝗰𝗿𝘂𝘇, 𝗕𝗿𝗮𝘇𝗶𝗹), 𝗮𝗻𝗱 𝗗𝗿. 𝗝𝗮𝗲𝘆𝗼𝘂𝗻𝗴 𝗔𝗵𝗻 (𝗦𝗞 𝗯𝗶𝗼𝘀𝗰𝗶𝗲𝗻𝗰𝗲). The discussion was moderated by 𝗗𝗿. 𝗔𝗺𝗮𝗱𝗼𝘂 𝗔𝗹𝗽𝗵𝗮 𝗦𝗮𝗹𝗹, 𝗘𝘅𝗲𝗰𝘂𝘁𝗶𝘃𝗲 𝗗𝗶𝗿𝗲𝗰𝘁𝗼𝗿, 𝗠𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴 & 𝗦𝘂𝗽𝗽𝗹𝘆 𝗖𝗵𝗮𝗶𝗻, 𝗖𝗘𝗣𝗜. Speaking on the future of vaccines, Dr. Anand Kumar highlighted the evolution of 𝗔𝗜-𝗲𝗻𝗮𝗯𝗹𝗲𝗱 𝘀𝘂𝗽𝗲𝗿𝗮𝗻𝘁𝗶𝗴𝗲𝗻 𝗱𝗲𝘀𝗶𝗴𝗻, which could potentially offer broad cross-protection against entire families of viruses and be applicable across multiple species. He also shared perspectives on emerging innovations such as 𝘁𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰 𝘃𝗮𝗰𝗰𝗶𝗻𝗲𝘀 𝗳𝗼𝗿 𝗰𝗮𝗻𝗰𝗲𝗿, 𝗶𝗻𝘃𝗲𝗿𝘀𝗲 𝘃𝗮𝗰𝗰𝗶𝗻𝗲𝘀 𝗳𝗼𝗿 𝗮𝘂𝘁𝗼𝗶𝗺𝗺𝘂𝗻𝗲 𝗱𝗶𝘀𝗲𝗮𝘀𝗲𝘀 𝘀𝘂𝗰𝗵 𝗮𝘀 𝗱𝗶𝗮𝗯𝗲𝘁𝗲𝘀 𝗮𝗻𝗱 𝗺𝘂𝗹𝘁𝗶𝗽𝗹𝗲 𝘀𝗰𝗹𝗲𝗿𝗼𝘀𝗶𝘀, and expressed confidence that advances in science and technology will accelerate the development of effective vaccines against 𝘁𝘂𝗯𝗲𝗿𝗰𝘂𝗹𝗼𝘀𝗶𝘀, 𝗛𝗜𝗩, 𝗮𝗻𝗱 𝗺𝗮𝗹𝗮𝗿𝗶𝗮. Dr. Kumar further emphasized how advanced computational models could rapidly evaluate the safety and efficacy of well-established vaccine platforms, such as 𝗟𝗶𝘃𝗲 𝗔𝘁𝘁𝗲𝗻𝘂𝗮𝘁𝗲𝗱 𝗩𝗮𝗰𝗰𝗶𝗻𝗲𝘀, enabling faster development and deployment of vaccines. He advocated for broader adoption of 𝗺𝗶𝗰𝗿𝗼𝗻𝗲𝗲𝗱𝗹𝗲 𝗽𝗮𝘁𝗰𝗵𝗲𝘀 and 𝗶𝗻𝘁𝗿𝗮𝗻𝗮𝘀𝗮𝗹 𝘃𝗮𝗰𝗰𝗶𝗻𝗲 𝗱𝗲𝗹𝗶𝘃𝗲𝗿𝘆 𝘀𝘆𝘀𝘁𝗲𝗺𝘀 to improve accessibility and patient acceptance. He also drew attention to the long-term implications of declining global fertility rates, noting that a reduction from the current annual birth cohort could significantly impact vaccine demand projections and manufacturing capacity planning across the industry. At 𝗜𝗻𝗱𝗶𝗮𝗻 𝗜𝗺𝗺𝘂𝗻𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹𝘀 𝗟𝗶𝗺𝗶𝘁𝗲𝗱, we remain committed to delivering affordable, high-quality vaccines and contributing to better health outcomes across the world through innovation, collaboration, and our shared vision of 𝗢𝗻𝗲 𝗛𝗲𝗮𝗹𝘁𝗵. #DCVMN2026 #IndianImmunologicals #IIL #OneHealth #GlobalHealth #Vaccines #VaccineIndustry #Innovation #PublicHealth #HealthSecurity #DCVMN #CEPI #VaccineInnovation #FutureOfVaccines

We are proud to announce that IIL has received the National Award for Energy Efficient Unit in Energy Management 2026 from the Confederation of Indian Industry (@FollowCII) for our Ooty site. This marks the fourth consecutive year that IIL has been recognized with a national energy efficiency award and the second consecutive year that our Ooty site has received this prestigious recognition in the Energy Management category. Speaking on the occasion, Dr K Anand Kumar, Managing Director, IIL, said that this is another example of responsible manufacturing. As a company committed to the One Health philosophy, IIL continues to integrate human health, animal health, and environmental sustainability into its operations. This achievement reflects our unwavering commitment to responsible energy management, sustainable manufacturing practices, and environmental stewardship. @NDDB_Coop #IIL #NDDB #OneHealth #CII

𝟰𝟬 𝗬𝗲𝗮𝗿𝘀. 𝗠𝗶𝗹𝗹𝗶𝗼𝗻𝘀 𝗼𝗳 𝗟𝗶𝘃𝗲𝘀 𝗧𝗼𝘂𝗰𝗵𝗲𝗱. 𝗢𝗻𝗲 𝗣𝘂𝗿𝗽𝗼𝘀𝗲. 𝗜𝗻𝗱𝗶𝗮𝗻 𝗜𝗺𝗺𝘂𝗻𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹𝘀 𝗟𝘁𝗱. is one of the region's largest biopharmaceutical companies, specializing in the development and manufacturing of human and veterinary vaccines. Our products are exported to more than 60 countries worldwide, and we are the market leader in India across both the human and animal health vaccine segments. 𝗜𝗻𝗱𝗶𝗮𝗻 𝗜𝗺𝗺𝘂𝗻𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹𝘀 𝗟𝗶𝗺𝗶𝘁𝗲𝗱 𝗶𝘀 𝗽𝗿𝗼𝘂𝗱 𝘁𝗼 𝗯𝗲 𝗽𝗮𝗿𝘁 𝗼𝗳 𝗖𝗣𝗛𝗜 𝗠𝗶𝗹𝗮𝗻 𝟮𝟬𝟮𝟲, 𝘄𝗵𝗲𝗿𝗲 𝗴𝗹𝗼𝗯𝗮𝗹 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗹𝗲𝗮𝗱𝗲𝗿𝘀 𝗰𝗼𝗺𝗲 𝘁𝗼𝗴𝗲𝘁𝗵𝗲𝗿 𝘁𝗼 𝗮𝗱𝘃𝗮𝗻𝗰𝗲 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗶𝗺𝗽𝗿𝗼𝘃𝗲 𝗽𝗮𝘁𝗶𝗲𝗻𝘁 𝗮𝗰𝗰𝗲𝘀𝘀 𝘄𝗼𝗿𝗹𝗱𝘄𝗶𝗱𝗲. As a trusted vaccine manufacturer with a growing international footprint, we look forward to discussing opportunities in: • Strategic Partnerships • Technology Collaborations • Market Expansion and Licensing • Contract Manufacturing We are delighted to invite you to visit us at 𝗦𝘁𝗮𝗻𝗱 𝟮𝟬𝗙𝟰𝟮 during 𝗖𝗣𝗛𝗜 𝗠𝗶𝗹𝗮𝗻 𝟮𝟬𝟮𝟲, taking place from 𝟲 𝘁𝗼 𝟴 𝗢𝗰𝘁𝗼𝗯𝗲𝗿 𝟮𝟬𝟮𝟲, to discuss potential collaboration opportunities and explore areas of mutual interest. 𝗧𝗼𝘂𝗰𝗵𝗶𝗻𝗴 𝗟𝗶𝘃𝗲𝘀. 𝗠𝗮𝗸𝗶𝗻𝗴 𝗮 𝗗𝗶𝗳𝗳𝗲𝗿𝗲𝗻𝗰𝗲. @CPHI_Events #CPHIMilan2026 #IndianImmunologicals #Vaccines #GlobalHealth #Biopharma #Partnerships #PharmaceuticalIndustry #Innovation #OneHealth #CPHIWorldWide #CPHI

On 80th Independence Day, Indian Immunologicals Limited (IIL) wishes happy Independence Day and salutes the brave hearts whose courage and sacrifice paved the way for a free India. As the nation moves forward, we remain committed to strengthening India’s healthcare and vaccine self-reliance through indigenous innovations. Let us honour the spirit of freedom by contributing to a healthier, stronger and more self-reliant India. Jai Hind! @NDDB_Coop #80thIndependenceDay #IndianImmunologicalsLimited #IIL #NDDB #IndependenceDay2026 #IndependenceDay #AtmanirbharBharat #HealthcareForIndia #JaiHind

Confederation of Indian Industry (@FollowCII) conducted its first ever “India Pet Care Summit” in Delhi on 5th Aug’26 at the Hyatt Regency Hotel in New Delhi. Dr K Anand Kumar, Managing Director IIL, was invited as a speaker to a panel discussion titled “From Conflict to Coexistence-Solving India’s Challenge on Stray Animals and Zoonosis along with other speakers including Ms Maneka Gandhi, Chairperson PFA, Dr.Pusph Lata, ADG, Ministry of Health and Family Welfare, Government of India, Ms.Mourya Boda, MD, Brilliant Biopharma. The session was moderated by Dr.Arun Atrey, MD, Zenex Animal Health. Dr.Anand Kumar expressed his views on the subject and gave details on how IIL is playing multiple roles in addressing Zoonosis by providing quality affordable vaccines, educating public through its special web pages and making significant contribution in this area through its CSR funds. He said that surveillance and incidence based approach should be used for the choice of vaccination. As incidence of Distemper virus and Parvovirus is high, he announced that IIL will roll out Monovalent vaccines against these diseases at a very affordable price. The announcement was well received by the audience. Representatives from Pet Food industry, diagnostics, animal health and vaccine industry, policy makers, NGOs, regulatory institutions etc attended the event. Dr NSN Bhargav, Sr VP and S Sobhanbabu, VP, IIL were also present. The event was inaugurated by Dr. Naveena Maheswarappa, Animal Husbandry Commissioner, Government of India. @NDDB_Coop #IIL #NDDB #OneHealth

𝗪𝗢𝗥𝗟𝗗 𝗛𝗘𝗣𝗔𝗧𝗜𝗧𝗜𝗦 𝗗𝗔𝗬 | 𝗣𝗥𝗢𝗧𝗘𝗖𝗧 𝗬𝗢𝗨𝗥 𝗟𝗜𝗩𝗘𝗥. 𝗣𝗥𝗢𝗧𝗘𝗖𝗧 𝗬𝗢𝗨𝗥 𝗟𝗜𝗙𝗘. Hepatitis A is not just a childhood infection. It is a highly contagious liver disease that can affect people of all ages and spreads through contaminated food and water. The burden is significant. India accounted for an estimated 𝟭𝟵% 𝗼𝗳 𝗴𝗹𝗼𝗯𝗮𝗹 𝗛𝗲𝗽𝗮𝘁𝗶𝘁𝗶𝘀 𝗔 𝗶𝗻𝗳𝗲𝗰𝘁𝗶𝗼𝗻𝘀, with approximately 𝟯𝟬.𝟲 𝗺𝗶𝗹𝗹𝗶𝗼𝗻 𝗰𝗮𝘀𝗲𝘀 𝗮𝗻𝗱 𝟭𝟯,𝟲𝟱𝟴 𝗱𝗲𝗮𝘁𝗵𝘀, contributing to nearly half of global Hepatitis A mortality.* Source: Global Burden of Disease Study 2021 The good news? 𝗛𝗲𝗽𝗮𝘁𝗶𝘁𝗶𝘀 𝗔 𝗶𝘀 𝗽𝗿𝗲𝘃𝗲𝗻𝘁𝗮𝗯𝗹𝗲. Practice good hand hygiene, drink safe water, eat hygienically prepared food, and most importantly, protect yourself and your family through vaccination. This 𝗪𝗼𝗿𝗹𝗱 𝗛𝗲𝗽𝗮𝘁𝗶𝘁𝗶𝘀 𝗗𝗮𝘆, let’s move from awareness to action. Talk to your doctor about Hepatitis A vaccination and take a step towards protecting yourself and your loved ones. 𝗣𝗥𝗢𝗧𝗘𝗖𝗧 𝗬𝗢𝗨𝗥 𝗟𝗜𝗩𝗘𝗥. 𝗣𝗥𝗢𝗧𝗘𝗖𝗧 𝗬𝗢𝗨𝗥 𝗟𝗜𝗙𝗘. 𝗚𝗲𝘁 𝗩𝗮𝗰𝗰𝗶𝗻𝗮𝘁𝗲𝗱. 𝗦𝘁𝗮𝘆 𝗣𝗿𝗼𝘁𝗲𝗰𝘁𝗲𝗱. 𝗪𝗼𝗿𝗹𝗱 𝗛𝗲𝗽𝗮𝘁𝗶𝘁𝗶𝘀 𝗗𝗮𝘆 | 𝟮𝟴 𝗝𝘂𝗹𝘆 #WorldHepatitisDay #HepatitisA #HepatitisAwareness #ProtectYourLiver #Vaccination #Prevention #PublicHealth #GetVaccinated #StayProtected #LetsBeatHepatitisA #vaccineswork #immunizewithpride

Indian Immunologicals Limited (IIL) wholeheartedly congratulates Dr. Meenesh Shah, Chairman, IIL & NDDB, on his appointment as Chairperson of the Executive Board of Institute of Rural Management Anand (IRMA). Under his impeccable guidance and leadership, IRMA is all set to touch newer milestones in its pursuit. @NDDB_Coop @IRMAOfficial79 #IIL #NDDB #OneHealth #Management #Leadership

Behind every protected life is a Doctor committed to prevention and compassionate care. Thank you for protecting lives and inspiring hope every day. Happy Doctors' Day! #HappyDoctorsDay #DoctorsDay #ThankYouDoctors #HealthcareHeroes #CompassionateCare #PreventiveCare #Healthcare #SavingLives